Skip to main content

Share story

AI Products Policy

Amazon blocks Meta's Muse and expands lawsuit against Perplexity

Amazon blocks Meta's Muse and expands lawsuit against Perplexity Image: Primary
Amazon blocked Meta's Muse shopping agent from Amazon.com and asked Meta to remove the retailer from the service, saying the agent did not identify itself and appeared to capture and store customer credentials. Meta has said Muse cannot see passwords or payment methods because user-supplied information is held in secure storage. Amazon also amended its federal complaint against Perplexity, alleging that Comet for iOS copied Amazon session cookies to Perplexity servers and accessed the retailer through a cloud browser. Perplexity has not responded to the amended complaint; its assistant feature on Amazon was temporarily disabled in May.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from The Next Web and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

Security
Security

Gyazo breach exposed metadata for 490 million images

A breach at screenshot-sharing service Gyazo exposed nearly 24 million customer records and an additional 490 million image-metadata records, Infosecurity Magazine reported. Attackers exploited an upload-server vulnerability, gain...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...